Berberine Capsules — Contract Manufacturing with Bioavailability-First Formulation


Payment Terms:

TT/LC/DP/PayPal/Western Union

Delivery Time:

3-4 weeks

MOQ:

2000 bottles


Category:

FDA
cGMP
ISO9001
ISO22000
HACCP
FSSC22000
HALAL
SC
REACH
DGM
DMF
ECOCERT
Eurofins
SGS

Product Description

Product Specifications

Parameter

Details

Active Ingredient

Berberine HCl (≥97% purity, HPLC-verified)

Dosage Strength

300 mg / 500 mg / 600 mg per capsule (customizable)

Botanical Source

Berberis aristata / Coptis chinensis / Berberis aquifolium (selectable)

Capsule Type

Size 00 / 0 / 1 (gelatin or HPMC vegan)

Serving Suggestion

500 mg × 2–3 capsules/day with meals

Shelf Life

24 months (controlled storage)

Certifications

ISO9001, ISO22000, FSSC22000, GMP, FDA-registered, HALAL

Annual Capacity

2 billion capsules (hard capsule line)


The Bioavailability Problem — And What Manufacturers Can Actually Do About It

Why Berberine Absorption Is So Low

Berberine faces four absorption barriers simultaneously:

Poor intestinal permeability — Berberine is a quaternary ammonium alkaloid with a permanent positive charge. It does not passively diffuse through intestinal epithelial cells the way neutral molecules do.

P-glycoprotein (P-gp) efflux — P-gp transporters in the intestinal wall actively pump berberine back into the gut lumen. This is the single largest barrier to absorption.

Extensive first-pass metabolism — What does get absorbed is rapidly metabolized by CYP450 enzymes in the liver and intestine before reaching systemic circulation.

Self-aggregation — Berberine molecules tend to cluster together in aqueous environments, forming larger aggregates that are even harder to absorb.

These four barriers compound. The result is that even high-dose berberine capsules deliver far less active compound to the body than the label suggests.

Five Formulation Strategies We Use to Address Absorption

We do not claim to have solved berberine's bioavailability problem completely — no one has. But we apply five evidence-based strategies that meaningfully improve the amount of berberine that reaches circulation.

Strategy 1: Botanical Source Selection

Not all berberine is the same. The alkaloid profile varies significantly by plant source:

Source Plant

Region

Key Characteristics

Berberis aristata (Indian Barberry)

India, Nepal

Highest berberine content in bark; well-studied in clinical trials

Coptis chinensis (Goldthread)

China, Japan

Traditional TCM source; contains coptisine as co-active

Berberis aquifolium (Oregon Grape)

North America

Contains additional alkaloids (jatrorrhizine, palmatine)

Hydrastis canadensis (Goldenseal)

North America

Endangered species; not recommended for sustainability reasons

We source primarily from Berberis aristata (bark extract) because the majority of positive clinical trials used material from this source. The 2008 Yin et al. head-to-head trial against metformin — one of the most cited berberine studies — used B. aristata-derived berberine HCl at 500 mg three times daily. Sourcing consistency matters when you want to replicate published results.

Strategy 2: Purity and Standardization Rigor

We verify every incoming batch of berberine HCl using HPLC at 345 nm (consistent with European Pharmacopoeia monograph requirements). Our specification:

Parameter

Our Standard

Industry Common

Berberine HCl content

≥98%

≥95%

Individual impurity

≤0.3%

≤0.5%

Total impurities

≤0.8%

≤1.0%

Heavy metals (Pb)

≤1.0 ppm

≤2.0 ppm

Residual solvents

ICH Q3C compliant

Basic compliance

Particle size

80–200 mesh (customizable)

Not always specified

Why does purity above 97% matter? Impurities like jatrorrhizine and palmatine are structurally related alkaloids that compete for the same absorption pathways. Higher purity means more berberine per molecule reaches the absorption site, rather than being occupied by co-extracted compounds.

Strategy 3: Particle Size Optimization

Berberine HCl has low aqueous solubility (approximately 5.5 mg/mL at 25°C). Smaller particle size increases the surface area available for dissolution in the gastrointestinal tract. We offer:

  • Standard grade: 80–100 mesh (suitable for most capsule filling)
  • Fine grade: 100–200 mesh (improved dissolution rate)
  • Micronized grade: <50 μm (upon request, for enhanced absorption)

Research published in ACS Omega (2025) demonstrated that reducing berberine particle size to below 200 nm using nanomilling, combined with silymarin complexation, increased AUC by 4.26-fold and Cmax by 4.10-fold (DOI: 10.1021/acsomega.5c05343). While we do not currently offer nano-formulation as standard, micronized particle size is a meaningful intermediate step.

Strategy 4: Co-Formulation with Absorption Enhancers

This is where formulation science adds the most value. Published research identifies several compounds that can improve berberine absorption:

Co-Active

Mechanism

Evidence Level

Silymarin (Milk Thistle)

P-gp inhibition; hepatoprotective synergy

Human PK data; 4× AUC improvement

Piperine (Black Pepper Extract)

CYP3A4 inhibition; reduced first-pass metabolism

Multiple studies; 20–30% improvement estimated

Phospholipids (lecithin)

Mixed micelle formation; enhanced membrane transport

Liposomal studies; 4× plasma increase

Tetrandrine

Direct P-gp inhibition

Preclinical; traditional co-use in TCM

Curcumin

CYP3A4 inhibition; complementary AMPK activation

Preclinical + mechanistic rationale

We offer berberine capsules co-formulated with silymarin (80 mg standardized to 80% silymarin) as our flagship absorption-enhanced option. This combination is supported by the most robust human data available and addresses both the absorption and the first-pass metabolism barriers simultaneously.

Strategy 5: Dosing Schedule Design

The clinical evidence consistently shows that divided dosing with meals outperforms single large doses. The standard positive-trial protocol is 500 mg three times daily with meals. Here is why this matters for your product design:

  • With food: Dietary fat stimulates bile secretion, which forms mixed micelles that enhance berberine solubilization and absorption.
  • Divided doses: Berberine has a short plasma half-life (approximately 4–6 hours). Taking 1500 mg as a single dose does not produce the same exposure as 500 mg × 3.
  • Meal-timed: Postprandial glucose is where berberine shows its strongest effect (via AMPK activation and GLUT4 translocation). Timing capsules with meals aligns peak plasma levels with the metabolic challenge.

We recommend our brand partners design their label directions around 500 mg, 2–3 capsules per day, taken 10–15 minutes before or during meals.


Understanding the Four Documented Pathways

What makes berberine interesting as a supplement ingredient is not just AMPK activation — it is the combination of four parallel mechanisms that together support metabolic health:

Pathway

What It Does

Shared with Metformin?

AMPK activation (via mitochondrial Complex I inhibition)

Enhances glucose uptake; suppresses hepatic glucose production

Yes (different upstream mechanism)

Alpha-glucosidase inhibition

Slows carbohydrate breakdown in the intestine; blunts post-meal glucose spikes

No

GLP-1 secretion stimulation

Supports insulin secretion; slows gastric emptying

No

Gut microbiome modulation

Increases SCFA-producing bacteria; modulates bile acid metabolism

No

Three of the four pathways are unique to berberine and not shared with metformin. This is relevant for brand positioning — berberine is not simply "natural metformin." It has a broader pharmacological profile that includes lipid modulation (LDL-C reduction of 20–25% via PCSK9 inhibition and LDLR upregulation) that metformin does not address.


Berberine Form Comparison — What Options Exist

The market is evolving beyond simple berberine HCl. Brand owners should understand the available forms when designing their product line:

Form

Bioavailability

Cost

Evidence Base

Best For

Berberine HCl

Low (baseline)

Low

Extensive (majority of clinical trials)

Standard formulations; cost-conscious positioning

Dihydroberberine (DHB)

Claimed ~5× higher

High

Limited; primarily preclinical

Premium positioning; biohacker audience

Berberine + Silymarin complex

~4× AUC improvement (human data)

Medium

Growing; human PK studies

Evidence-backed premium formulations

Liposomal Berberine

~4× plasma increase (pilot study, n=6)

High

Early-stage; small sample size

Innovation-focused brands

Berberine organic acid salts (fumarate/succinate)

Higher than HCl (animal data)

Medium

Preclinical

Formulation diversification

We currently manufacture standard berberine HCl capsules and berberine + silymarin co-formulated capsules as our two primary offerings. For brands interested in DHB or liposomal formats, we can discuss custom development timelines.


Customization Options

Capsule Size: Size 00 (≈750 mg fill), Size 0 (≈500 mg fill), Size 1 (≈400 mg fill)

Shell Type:

  • Bovine gelatin (standard)
  • HPMC (vegan, suitable for plant-based brands)
  • Pullulan (premium vegan option)

Fill Options:

  • Berberine HCl alone (300 mg / 500 mg / 600 mg)
  • Berberine HCl + Silymarin extract (80% silymarin)
  • Berberine HCl + complementary ingredients (piperine, curcumin, chromium, alpha-lipoic acid — custom formulas available)

Label & Packaging:

  • Private label with your brand design
  • Bulk packaging (bottles, blister packs, sachets)
  • Custom bottle count: 30 / 60 / 90 / 120 capsules

Certification Support:

  • We can support NSF, USP, or third-party testing registration for your brand
  • COA, TDS, and MSDS provided with every batch

Quality Control — From Source to Finished Capsule

Checkpoint

What We Test

Method

Raw material incoming

Berberine HCl purity, heavy metals, residual solvents, microbiology

HPLC, ICP-MS, GC, plate count

In-process

Fill weight uniformity, content uniformity, disintegration

USP <905>, USP <711>

Finished product

Assay, dissolution, heavy metals, microbiology, identity

HPLC, ICP-MS, PCR (for botanical ID)

Stability

Accelerated (40°C/75% RH) and real-time (25°C/60% RH) at 6/12/18/24 months

ICH Q1A guidelines

Every batch is traceable from the finished capsule back to the specific lot of raw berberine extract, including the botanical source, harvest date, and extraction batch.


Comparison: Market Standard vs. Our Approach

Dimension

Market Standard

Our Approach

Berberine source

Often unspecified or mixed

Single-source, documented botanical origin

Purity standard

≥95%

≥98% (Ph. Eur. aligned)

Bioavailability strategy

None (raw HCl only)

Silymarin co-formulation + particle size optimization + dosing guidance

Testing

Outgoing assay only

Full incoming + in-process + outgoing + stability

Technical support

Specs and MOQ

Formulation consultation, regulatory guidance, label review

MOQ

100–500 bottles

100,000 capsules (flexible for new brands)


Frequently Asked Questions

Q: Why is berberine's bioavailability so low, and can it really be improved in a capsule format?

A: Berberine HCl has an absolute oral bioavailability below 1% due to poor intestinal permeability, P-glycoprotein efflux, first-pass liver metabolism, and self-aggregation in aqueous environments. While no single solution eliminates all four barriers, a combination approach — co-formulation with P-gp inhibitors (like silymarin), optimized particle size, and proper dosing timing with meals — can meaningfully improve the amount that reaches circulation. Human pharmacokinetic data shows silymarin co-formulation achieves a 4.26-fold increase in AUC.

Q: What is the difference between berberine HCl and dihydroberberine (DHB)?

A: Berberine HCl is the standard, well-studied form used in the majority of clinical trials. DHB is a reduced form that reportedly has approximately 5× greater oral bioavailability in preclinical models, but human clinical evidence is limited. DHB is significantly more expensive. For brands that want to stay close to the published clinical evidence base, berberine HCl (especially with absorption-enhancing co-formulation) remains the safer choice. DHB may be suitable for premium brands targeting the biohacker segment.

Q: Can I combine berberine with other metabolic support ingredients in one capsule?

A: Yes. We commonly co-formulate berberine with ingredients like silymarin (liver support + absorption enhancement), piperine (CYP3A4 inhibition), curcumin (complementary AMPK activation), chromium picolinate (glucose metabolism), and alpha-lipoic acid (antioxidant + insulin sensitivity). We can develop custom combination formulas based on your target positioning and regulatory requirements.

Q: What dose should I put on my label?

A: The clinical evidence most consistently supports 500 mg taken 2–3 times daily with meals (total 1000–1500 mg/day). Dose-response data suggests 500 mg/day achieves approximately 70% of the peak effect, with diminishing returns above 1500 mg/day. We recommend designing your serving size so that consumers can achieve 1000–1500 mg/day through 2–3 capsules.

Q: Is berberine suitable for vegan products?

A: Yes. We offer HPMC (vegetarian) and pullulan capsule shells for berberine formulations. The berberine HCl raw material itself is plant-derived (extracted from Berberis or Coptis species), so the active ingredient is inherently vegan.

Q: What certifications do you hold for berberine capsule manufacturing?

A: Our facility holds ISO9001, ISO22000, FSSC22000, GMP, and FDA registration. We also hold HALAL certification. We can support your brand in obtaining NSF, USP verification, or other third-party certifications as needed.

Q: What is the MOQ for berberine capsules?

A: Our standard minimum order is 100,000 capsules. For new brands launching their first SKU, we can discuss smaller trial batches. Pricing depends on capsule size, shell type, formula complexity, and packaging requirements — contact us for a detailed quote.


Ready to Discuss Your Berberine Product?

Contact us with your target specifications, and we will prepare a formulation proposal within 48 hours. Our team includes formulation specialists who can advise on absorption optimization, regulatory compliance, and market positioning for berberine supplements.

Related articles:

Related Products:

Get a Free Quote

If you need more information about our products, please feel free to contact us, we will provide you with professional service personnel, we will reply promptly after receiving the information.

  • What products do you need?
  • How much do you need?
  • What other information do you need to know?
Security verification
Submit

FAQ

Q

Can you customize product formulations based on cross-border market demands?


A

Absolutely, we can tailor product formulations to meet local consumer preferences and regulatory requirements in your target markets.

Q

Can you provide multilingual labeling and instructions for cross-border products?


A

Certainly, we offer multilingual labeling and instructions to ensure accurate communication of product information in different countries' markets.

Q

What is the MOQ for cross-border business?


A

Our cross-border business MOQ is low, typically ranging from 1000 to 5000 units of products, and can be flexibly adjusted based on specific circumstances.

Q

Can you directly ship to overseas warehouses or facilitate split shipments?


A

We support direct delivery to overseas warehouses and can arrange split shipments according to your needs. We have well-established global logistics solutions.

Q

Do you support commonly used payment methods for cross-border markets?


A

Yes, we support widely used cross-border payment settlement methods such as PayPal, credit cards, and TT bank transfers.

Q

Can you provide import customs clearance documents for major countries?


A

Yes, we can provide customs registration information, inspection reports, and other customs clearance documents for different countries.

Q

Does your product packaging design comply with regulatory requirements in major countries?


A

Our product packaging design can be adjusted to meet the regulatory standards and requirements of different countries, ensuring compliance with local norms. 

Q

Can you conduct small-scale production for cross-border testing?


A

Certainly,we welcome small-scale trial orders. We have dedicated small-scale production lines available for cross-border market testing,assisting you in evaluating market potential and feedback.